UPDATE: Baird Starts Aimmune Therapeutics (AIMT) at Outperform; Positive Into Q18 PALISADE Data
Tweet Send to a Friend
(Updated - December 20, 2017 4:11 PM EST)
(updated to add analyst comments)Baird initiates coverage on Aimmune Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comments)Baird initiates coverage on Aimmune Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
